Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

Wake Up Narcolepsy Announces Inaugural Bridging Perspectives Convening

Narcolepsy and the Fractured Self: Grieving, Growing and Reclaiming Identity

Obstructive Sleep Apnea Research from Home

Join Us for September’s Brown Bag Webinar – Understanding and Managing Cataplexy

Wake Up Narcolepsy Launches Second Year of Worldwide Step Up For Sleep

Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1

The KYRA Study is exploring options for those with narcolepsy without cataplexy

Join Us for August’s Brown Bag Webinar – Navigating Communication about Invisible, Chronic Illnesses